Source:http://linkedlifedata.com/resource/pubmed/id/19913863
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2009-12-7
|
pubmed:databankReference | |
pubmed:abstractText |
CCR5-using (R5) human immunodeficiency virus type 1 (HIV-1) strains cause CD4+ T-cell loss in most infected individuals, but mechanisms underlying cytopathicity of R5 viruses are poorly understood. We investigated mechanisms contributing to R5 envelope glycoprotein (Env)-mediated cellular apoptosis by constructing a panel of retroviral vectors engineered to co-express GFP and R5 Envs derived from two HIV-1-infected subjects spanning asymptomatic (Early, E-R5 Envs) to late stages of infection (Late, L-R5 Envs). The L-R5 Envs induced significantly more cellular apoptosis than E-R5 Envs, but only in Env-expressing (GFP-positive) cells, and only in cells where CD4 and CCR5 levels were limiting. Studies with fusion-defective Env mutants showed induction of apoptosis required membrane-fusing events. Our results provide evidence for an intracellular mechanism of R5 Env-induced apoptosis of CD4+ cells that requires membrane fusion. Furthermore, they contribute to a better understanding of mechanisms involved in CD4+ T-cell loss in subjects experiencing progressive R5 HIV-1 infection.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1096-0341
|
pubmed:author |
pubmed-author:ChiavaroliLisaL,
pubmed-author:ChurchillMelissaM,
pubmed-author:CowleyDanielD,
pubmed-author:EllettAnneA,
pubmed-author:FenyöEva-MariaEM,
pubmed-author:GorryPaul RPR,
pubmed-author:GrayLachlanL,
pubmed-author:JakobsenMartin RMR,
pubmed-author:KarlssonIngridI,
pubmed-author:PereiraCandida da FonsecaCda F,
pubmed-author:PurcellDamian F JDF,
pubmed-author:RocheMichaelM,
pubmed-author:SaksenaNitinN,
pubmed-author:SterjovskiJasminkaJ,
pubmed-author:WadeJessicaJ,
pubmed-author:WoodR WRW
|
pubmed:issnType |
Electronic
|
pubmed:day |
20
|
pubmed:volume |
396
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
246-55
|
pubmed:meshHeading |
pubmed-meshheading:19913863-Apoptosis,
pubmed-meshheading:19913863-CD4-Positive T-Lymphocytes,
pubmed-meshheading:19913863-Cloning, Molecular,
pubmed-meshheading:19913863-Disease Progression,
pubmed-meshheading:19913863-HIV Envelope Protein gp120,
pubmed-meshheading:19913863-HIV Infections,
pubmed-meshheading:19913863-HIV-1,
pubmed-meshheading:19913863-Humans,
pubmed-meshheading:19913863-Molecular Sequence Data,
pubmed-meshheading:19913863-Receptors, CCR5,
pubmed-meshheading:19913863-Transduction, Genetic,
pubmed-meshheading:19913863-Virulence,
pubmed-meshheading:19913863-Virus Attachment,
pubmed-meshheading:19913863-Virus Internalization
|
pubmed:year |
2010
|
pubmed:articleTitle |
Enhanced CD4+ cellular apoptosis by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with progressive HIV-1 infection.
|
pubmed:affiliation |
Center for Virology, Burnet Institute, Melbourne, Victoria, Australia.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|